Detalhe da pesquisa
1.
Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial.
AIDS Res Ther
; 19(1): 2, 2022 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35022035